Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic.

Autor: Kondapalli L; University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Arora G; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Hawi R; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Andrikopoulou E; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Estes C; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Patel N; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Lenneman CG; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA. clenneman@uabmc.edu.

Publikováno v: Current treatment options in oncology [Curr Treat Options Oncol] 2022 Sep; Vol. 23 (9), pp. 1288-1302. Date of Electronic Publication: 2022 Aug 15.

Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors.

Autor: Kondapalli L; Department of Medicine, Division of Cardiology, University of Colorado, Aurora, CO, USA., Worth S; Department of Pharmacy, University of Alabama at Birmingham, Birmingham, AL, USA., Hawi R; Department of Medicine, Division of Cardiology, University of Alabama at Birmingham, Birmingham, AL, USA., Vachhani P; Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Arora G; Department of Medicine, Division of Cardiology, University of Alabama at Birmingham, Birmingham, AL, USA., Bhatia R; Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Lenneman CG; Department of Medicine, Division of Cardiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Publikováno v: Vascular medicine (London, England) [Vasc Med] 2020 Jun; Vol. 25 (3), pp. 246-254. Date of Electronic Publication: 2020 Apr 17.

Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.

Autor: Bolli R; University of Louisville, Louisville, KY., Hare JM; University of Miami Miller School of Medicine, Miami, Florida., Henry TD; Cedars-Sinai Heart Institute, Los Angeles, California., Lenneman CG; University of Louisville, Louisville, KY., March KL; Indiana University School of Medicine, Indianapolis, Indiana., Miller K; Indiana University School of Medicine, Indianapolis, Indiana., Pepine CJ; University of Florida School of Medicine, Gainesville, Florida., Perin EC; Texas Heart Institute, CHI St. Luke's Health, Houston, TX., Traverse JH; Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN., Willerson JT; Texas Heart Institute, CHI St. Luke's Health, Houston, TX., Yang PC; Stanford University School of Medicine, Stanford, California., Gee AP; Baylor College of Medicine, Houston, TX., Lima JA; Johns Hopkins University, Baltimore, MD., Moyé L; UT Health School of Public Health, Houston, TX. Electronic address: lemmoye@msn.com., Vojvodic RW; UT Health School of Public Health, Houston, TX., Sayre SL; UT Health School of Public Health, Houston, TX., Bettencourt J; UT Health School of Public Health, Houston, TX., Cohen M; UT Health School of Public Health, Houston, TX., Ebert RF; NIH, National Heart, Lung, and Blood Institute, Bethesda, MD., Simari RD; University of Kansas School of Medicine, Kansas City, Kansas.

Publikováno v: American heart journal [Am Heart J] 2018 Jul; Vol. 201, pp. 54-62. Date of Electronic Publication: 2018 Apr 04.

A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure.

Autor: Lenihan DJ; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, Tennessee., Anderson SA; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, Tennessee., Lenneman CG; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, Tennessee., Brittain E; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, Tennessee., Muldowney JAS 3rd; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, Tennessee., Mendes L; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, Tennessee., Zhao PZ; Acorda Therapeutics, Inc., Ardsley, New York., Iaci J; Acorda Therapeutics, Inc., Ardsley, New York., Frohwein S; Emory Heart and Vascular Center at Emory Saint Joseph's, Atlanta, Georgia., Zolty R; University of Nebraska Medical Center, Omaha, Nebraska., Eisen A; Acorda Therapeutics, Inc., Ardsley, New York., Sawyer DB; Maine Medical Center, Portland, Maine., Caggiano AO; Acorda Therapeutics, Inc., Ardsley, New York.

Publikováno v: JACC. Basic to translational science [JACC Basic Transl Sci] 2016 Dec 26; Vol. 1 (7), pp. 576-586. Date of Electronic Publication: 2016 Dec 26 (Print Publication: 2016).

Getting the SCOOP-Survey of Cardiovascular Outcomes From Oncology Patients During Survivorship.

Autor: Bhatia N; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: dr.bhatia.n@gmail.com., Lenihan D; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Sawyer DB; Division of Cardiovascular Medicine, Department of Medicine, Maine Medical Center, Portland, Maine., Lenneman CG; Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky.

Publikováno v: The American journal of the medical sciences [Am J Med Sci] 2016 Jun; Vol. 351 (6), pp. 570-5. Date of Electronic Publication: 2016 Mar 31.